Search Results Search Sort by RelevanceMost Recent Policy Forum Jan 2007 Setting Fair Prices for Life-Saving Drugs Bruce A. Chabner, MD and Thomas G. Roberts Jr, MD, MSocSci Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007;9(1):38-43. doi: 10.1001/virtualmentor.2007.9.1.pfor1-0701. State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701. Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494. Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Current page 19
Policy Forum Jan 2007 Setting Fair Prices for Life-Saving Drugs Bruce A. Chabner, MD and Thomas G. Roberts Jr, MD, MSocSci Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007;9(1):38-43. doi: 10.1001/virtualmentor.2007.9.1.pfor1-0701.
State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701.
Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494.